课题基金 / 基金详情

Rational design of a novel rapid diagnostic tool for coccidioidomycosis

Rational design of a novel rapid diagnostic tool for coccidioidomycosis
合理设计新型球孢子菌病快速诊断工具
批准号:
10668184
负责人:
Bridget Marie Barker
金额:
$25.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-01-23 至 2024-12-31
关键词:
AffinityAnimalsAnti-Bacterial AgentsAntibodiesAntifungal AgentsAntigensAreaBioinformaticsBiologicalBiological AssayBiological MarkersBiosensorBloodCenters for Disease Control and Prevention (U.S.)Central AmericaClinicalClinical TrialsCoccidioidesCoccidioides immitisCoccidioides posadasiiCoccidioidomycosisCoupledDataData AnalysesDependenceDetectionDevelopmentDiagnosisDiagnosticDiagnostic testsDiseaseEngineeringEscherichia coliEvaluationFiltrationFutureGene ProteinsGenesGenomicsGoalsHarvestHealth Care CostsHumanHydrocortisoneImageryImmune responseIn VitroIncidenceIndustryInfectionIntellectual PropertyLaboratoriesLength of StayMarketingMethodologyMethodsMolecularMusMycosesOutcome StudyPatient-Focused OutcomesPatientsPerformancePhasePolymersProcessProtein SecretionProteinsProviderRapid diagnosticsRecombinant ProteinsRecombinantsReportingReproducibilityResearchResource-limited settingSamplingSerodiagnosesSerumSoilSouth AmericaSouthwestern United StatesSpecificityStructure of parenchyma of lungSymptomsSystemTechniquesTestingTranscriptUnited StatesUp-RegulationValidationaccurate diagnosisantibody testantigen diagnosticantigen testbacterial communitybioelectronicsbiomarker validationcandidate selectioncommunity acquired pneumoniacostdesert feverdesigndetection limitdiagnostic assaydiagnostic tooleffective therapyexperimental studyfungusgenomic dataimprintimprovedin silicoin vivoinnovationinterdisciplinary approachmanufacturemodel organismnovelnovel diagnosticsnovel strategiespathogenic fungusperipheral bloodradiological imagingrapid diagnosisrational designreagent testingscreeningsensorstatisticssynthetic antibodiessynthetic biologytime usetranscriptome sequencing

项目摘要

项目成果

Bridget Marie Barker的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Coccidioides immitis and C. posadasii are two species of soil fungi that cause the disease coccidioidomycosis, (or Valley fever), whose incidence has increased 587% over the last 20 years and now causes over 150,000 new infections in the United States annually. The Centers for Disease Control and Prevention (CDC) report that average cost for treating Valley fever is over $50,000 per patient and delays or misdiagnosis of Valley fever result in an average of $590,000 in extra healthcare costs, including extensive hospital stays and a lifetime of treatment. Current Valley fever diagnostic tests are based on proprietary antibodies or antigens, which may not be easily accessed. We propose that advanced genomic analyses of these fungal pathogens can support the identification of new biomarkers and embody the foundational framework that is necessary for development of new diagnostic tools. We aim to improve the diagnostics available for detection of Coccidioides spp. by analyzing existing genomic data and using in silico predictions to identify several putative antigens that are highly expressed during host infection and would likely interact with the host. We will express these novel antigens along with standard control CF and TP antigens from Coccidioides in a model organism (Escherichia coli) and use the protein products to create an electrochemical sensor Molecularly Imprinted Polymer (MIP) diagnostic assay. MIPs are a polymer that has been processed using a molecular imprinting technique which leaves cavities in the polymer matrix with high affinity for a chosen ‘template’ molecule (in our case the antigens expressed by E. coli). When paired with an electrochemical biosensor, MIPs can be the basis for a low-cost diagnostic tool because they mimic biological recognition well enough to be called ‘synthetic antibodies.’ In total, this proposal represents a unique pairing of advanced genomic data analysis and novel diagnostic development in an important, yet understudied, fungal pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
  • 批准号:
    10356628
  • 项目类别:
  • 资助金额:
    $26.32万
  • 财政年份:
    2022
  • 负责人:
    Bridget Marie Barker
  • 依托单位:
CRISPR and Virulence Core
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
  • 批准号:
    10689668
  • 项目类别:
  • 资助金额:
    $45.29万
  • 财政年份:
    2022
  • 负责人:
    Bridget Marie Barker
  • 依托单位:
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
  • 批准号:
    10356627
  • 项目类别:
  • 资助金额:
    $27.47万
  • 财政年份:
    2022
  • 负责人:
    Bridget Marie Barker
  • 依托单位:
海外基金